{"nct_id":"NCT04353492","title":"An Open-label Study Evaluating Ofatumumab Treatment Effectiveness and PROs in Subjects With RMS Transitioning From Fumarate-based RMS Approved Therapies or Fingolimod to Ofatumumab","status":"COMPLETED","status_verified_date":"2025-05","start_date":"2020-07-14","start_date_type":"ACTUAL","primary_completion_date":"2024-10-09","primary_completion_date_type":"ACTUAL","completion_date":"2025-03-11","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["NVS"]}